Moomoo AI 已提取核心信息
On December 31, 2023, Viking Global Investors LP and related entities and individuals, including Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott, and Rose S. Shabet (collectively referred to as the Reporting Persons), filed an amendment to their Schedule 13G with the SEC, disclosing an 8.8% ownership stake in Ginkgo Bioworks Holdings, Inc. This stake amounts to 143,085,126 shares of Class A common stock. The filing indicates that the shares are beneficially owned and that the Reporting Persons have shared voting and dispositive power over these shares. The ownership percentage is based on 1,619,442,071 shares of Common Stock outstanding as of October 31, 2023, as reported by Ginkgo Bioworks in its quarterly report. The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, indicating that the shares were not acquired with the purpose or effect of changing or influencing the control of the issuer.
On December 31, 2023, Viking Global Investors LP and related entities and individuals, including Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott, and Rose S. Shabet (collectively referred to as the Reporting Persons), filed an amendment to their Schedule 13G with the SEC, disclosing an 8.8% ownership stake in Ginkgo Bioworks Holdings, Inc. This stake amounts to 143,085,126 shares of Class A common stock. The filing indicates that the shares are beneficially owned and that the Reporting Persons have shared voting and dispositive power over these shares. The ownership percentage is based on 1,619,442,071 shares of Common Stock outstanding as of October 31, 2023, as reported by Ginkgo Bioworks in its quarterly report. The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, indicating that the shares were not acquired with the purpose or effect of changing or influencing the control of the issuer.
2023年12月31日，维京环球投资有限责任公司及相关实体和个人，包括维京环球机会母公司GP LLC、维京环球机会GP LLC、维京全球机会流动性不足投资次级有限责任公司、O. Andreas Halvorsen、David C. Ott和Rose S. Shabet（统称为申报人），向美国证券交易委员会提交了附表13G修正案，披露了8.8％ Ginkgo Bioworks Holdings, Inc. 的所有权。该股份相当于A类股份的143,085,126股普通股。该文件表明，这些股份是实益所有的，申报人对这些股票拥有共同的投票权和处置权。所有权百分比基于Ginkgo Bioworks在其季度报告中公布的截至2023年10月31日已发行的1,619,442,071股普通股。该文件是根据1934年《证券交易法》第13d-1（c）条提交的，表明收购股票的目的或效果不是为了改变或影响发行人的控制权。
2023年12月31日，维京环球投资有限责任公司及相关实体和个人，包括维京环球机会母公司GP LLC、维京环球机会GP LLC、维京全球机会流动性不足投资次级有限责任公司、O. Andreas Halvorsen、David C. Ott和Rose S. Shabet（统称为申报人），向美国证券交易委员会提交了附表13G修正案，披露了8.8％ Ginkgo Bioworks Holdings, Inc. 的所有权。该股份相当于A类股份的143,085,126股普通股。该文件表明，这些股份是实益所有的，申报人对这些股票拥有共同的投票权和处置权。所有权百分比基于Ginkgo Bioworks在其季度报告中公布的截至2023年10月31日已发行的1,619,442,071股普通股。该文件是根据1934年《证券交易法》第13d-1（c）条提交的，表明收购股票的目的或效果不是为了改变或影响发行人的控制权。
有用
没用